Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
January 30, 2007

Laureate Pharma to Manufacture Trubion’s Cancer Candidate

  • Laureate Pharma will produce Trubion Pharmaceuticals’ non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) drug candidate. TRU-016 targets CD37, an antigen present on B cells.

    The company expects to file an IND for TRU-016 in the second half of 2007 after completing preclinical testing.
    Trubion currently retains all development and commercialization rights for the TRU-016 program.

  • You’re all set! Thank you for subscribing to GEN Highlights.